In Vivo Data Analysis

Intended for the following roles:

• In vivo pharmacologists: designing and running animal studies, monitoring efficacy/toxicity, collecting behavioral and physiological data

• Toxicologists: evaluating safety and dose-response in animal models

• Pre-clinical data scientists /biostatisticians: analyzing high-dimensional experimental data

---

Preclinical in vivo studies routinely collect video or sensor data to assess animal behavior, motor function, nociception, social interaction, and other phenotypes. Historically these endpoints were scored manually or with simple heuristics. Recent work shows that ML approaches, particularly markerless pose estimation combined with supervised or unsupervised classifiers, can extract quantitative, time-resolved features and classify behaviors at scale. These methods are documented in peer reviewed literature and in comparative surveys of open source and commercial pipelines. PubMed, PubMed, CentralFrontiers

Challenges

Manual scoring is time consuming, subject to interrater variability, and limited in temporal or spatial resolution. Small or transient effects may be missed. In multi-site projects, variable camera setups and annotation conventions further complicate pooling data. Any analytical approach intended to inform safety or dose decisions must therefore be reproducible, auditable, and robust to domain differences.

AI techniques

Markerless pose estimation (for example DeepLabCut and related toolchains) produces skeletal keypoint time series from raw video. These kinematics can be used directly or fed into downstream machine learning classifiers for ethogram scoring, unsupervised discovery of behavior motifs, or quantitative feature extraction for statistical analysis. Multiple pipelines exist, both open source and commercial; comparative studies evaluate trade offs in accuracy, usability, and generalizability. PubMed, GitHub, PubMed Central

Published examples

• Mathis et al., DeepLabCut, introduced markerless pose estimation across species and showed transfer learning reduced annotation needs for new animals and tasks. PubMed, GitHub

• Wiltschko et al. and related work combined pose representations with supervised classifiers to score ethological behaviors with performance comparable to human annotators on benchmark tasks. PubMed Central

• Recent comparative and survey papers document the landscape of automated rodent behavioral analysis tools and report consistent gains in throughput and intra-annotator consistency when methods are validated on task-specific datasets. Frontiers, PubMed Central

Before adopting these methods…

1. Performance is task and domain specific. Published reports of human-comparable accuracy refer to defined tasks and curated benchmark datasets. Extrapolation to new behaviors, camera angles, or lighting conditions requires revalidation. Nature PubMed Central

2. Domain shift is a material risk. Models trained in one laboratory or with one camera configuration can perform worse on external data unless transfer learning or retraining with representative samples is performed. Nature

3. Annotation quality matters. Supervised classifiers depend on consistent, well documented annotations. Interrater consensus procedures reduce label noise and improve downstream model reliability. PubMed Central

4. GLP and auditability. For analyses that feed safety or regulatory endpoints, software and pipelines must be managed under applicable GLP principles and institutional quality systems. Validation, version control, and data provenance are required to support audit and regulatory review. OECDaiforia.com

5. Open source versus commercial trade offs. Open source tools give flexibility and transparency but require in-house expertise to validate and maintain. Commercial platforms may package validation and support but evaluation is still required for provenance, performance, and governance. Comparative reviews are available. Frontiers, PubMed Central

Pilot validation checklist

Use this checklist before using automated outputs for study decisions.

1. Define intended use and decision consequence

   1. Specify which downstream decision the model output will inform and the acceptable error modes. (Document in protocol.)

2. Assemble representative development and hold-out datasets

   1. Include animals, strains, cages, and camera setups representative of planned use.

   2. Reserve an external hold-out set from a separate cohort or site for final verification.

3. Annotation protocol and inter-rater assessment

   1. Create a written annotation guide with examples.

   2. Measure inter-rater agreement and resolve discrepancies before model training.

4. Train and evaluate with predefined metrics and confidence intervals

   1. Report sensitivity, specificity, precision, recall, and where relevant F1 or area under curve, with 95% confidence intervals. Use metrics aligned to the decision context.

5. Assess robustness to common domain shifts

   1. Test model performance on variations in lighting, camera angle, animal coat color, and background. Document failure cases.

6. Version control and provenance capture

   1. Store model version, training data snapshot, training configuration, and random seeds. Ensure reproducible pipelines for inference and retraining.

7. Expert-in-the-loop review for safety-critical calls

   1. Maintain blinded human review for endpoints that affect dose or stop decisions, at least until prospective verification is complete.

8. GLP alignment and documentation

   1. Map the pipeline to institutional GLP procedures and OECD or national GLP principles. Prepare documentation enabling audit of software validation and data lineage.

Recommended experiment design patterns

• Start with narrow, high-value endpoints where the model reduces manual burden but does not alone determine safety decisions. Use these pilots to collect the additional labeled data needed for broader deployment.

• Use transfer learning with a small, task-specific labeled set to adapt pre-trained pose models rather than training from scratch, per published methodology.

• Blind validation to treatment assignment where possible to prevent label leakage during annotation and evaluation.

Resources

• Mathis A et al. DeepLabCut: markerless pose estimation of user-defined body parts with deep learning. Nat Neurosci 2018. PubMed

• Pereira TD et al. Deep learning-based behavioral analysis reaches human accuracy. Nat Commun/Transl Psychiatry and related implementations. PubMed Central Nature

• Big behavior: challenges and opportunities in a new era of deep learning for behavior. Review. PubMed Central

• Open-source software for automated rodent behavioral analysis. Frontiers in Neuroscience review 2023. Frontiers

• Comparative analyses of behavior pipelines (DeepLabCut, SimBA, others). PubMed Central

• SuperAnimal pretrained models and issues in generalization. Nat Commun 2024. Nature

• OECD Principles of Good Laboratory Practice. OECD

• GLP and AI-assisted image analysis guidance and vendor resources. aiforia.com